Reference
Orlov SV, et al. Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab. Case Reports in Oncology 13: 985-989, No. 2, May-Aug 2020. Available from: URL: http://doi.org/10.1159/000509241
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1834, 30 (2020). https://doi.org/10.1007/s40278-020-87222-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-87222-7